Literature DB >> 16444668

Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.

Pattipati S Naidu1, Amanpreet Singh, Shrinivas K Kulkarni.   

Abstract

Tardive dyskinesia is one of the major side effects of long-term neuroleptic treatment. The pathophysiology of this disabling and commonly irreversible movement disorder is still obscure. Vacuous chewing movements in rats are widely accepted as an animal model of tardive dyskinesia. Oxidative stress and products of lipid peroxidation are implicated in the pathophysiology of tardive dyskinesia. Repeated treatment with reserpine (1.0 mg/kg) on alternate days for a period of 5 days (days 1, 3 and 5) significantly induced vacuous chewing movements and tongue protrusions in rats. Chronic treatment with Withania somnifera root extract (Ws) for a period of 4 weeks to reserpine treated animals significantly and dose dependently (50 and 100 mg/kg) reduced the reserpine-induced vacuous chewing movements and tongue protrusions. Reserpine treated animals also showed poor retention of memory in the elevated plus maze task paradigm. Chronic Ws administration significantly reversed reserpine-induced retention deficits. Biochemical analysis revealed that chronic reserpine treatment significantly induced lipid peroxidation and decreased the glutathione (GSH) levels in the brains of rats. Chronic reserpine treated rats showed decreased levels of antioxidant defense enzymes, superoxide dismutase (SOD) and catalase. Chronic administration of Ws root extract dose dependently (50 and 100 mg/kg) and significantly reduced the lipid peroxidation and restored the decreased glutathione levels by chronic reserpine treatment. It also significantly reversed the reserpine-induced decrease in brain SOD and catalase levels in rats. The major findings of the present study indicate that oxidative stress might play an important role in the pathophysiology of reserpine-induced abnormal oral movements. In conclusion, Withania somnifera root extract could be a useful drug for the treatment of drug-induced dyskinesia. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444668     DOI: 10.1002/ptr.1823

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  12 in total

Review 1.  Nootropic and Anti-Alzheimer's Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer's Neuropathology.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Md Jakaria; Bijo Mathew; George E Barreto; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2018-11-09       Impact factor: 5.590

2.  Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis.

Authors:  Aparna Raghavan; Zahoor A Shah
Journal:  Mol Neurobiol       Date:  2014-10-08       Impact factor: 5.590

3.  Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats.

Authors:  Romaiana Picada Pereira; Roselei Fachinetto; Alessandro de Souza Prestes; Caroline Wagner; Jéssie Haigert Sudati; Aline Augusti Boligon; Margareth Linde Athayde; Vera Maria Morsch; João Batista Teixeira Rocha
Journal:  J Neural Transm (Vienna)       Date:  2011-04-08       Impact factor: 3.575

4.  Computational studies evidenced the potential of steroidal lactone to disrupt surface interaction of SARS-CoV-2 spike protein and hACE2.

Authors:  Ajay Yadav; Monu Dinesh Ojha; P Hariprasad
Journal:  Comput Biol Med       Date:  2022-05-13       Impact factor: 6.698

5.  Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment.

Authors:  Md Ejaz Ahmed; Hayate Javed; Mohd Moshahid Khan; Kumar Vaibhav; Ajmal Ahmad; Andleeb Khan; Rizwana Tabassum; Farah Islam; Mohammed M Safhi; Fakhrul Islam
Journal:  Protoplasma       Date:  2013-01-23       Impact factor: 3.356

6.  Comparative effects of Rauwolfia vomitoria and chlorpromazine on social behaviour and pain.

Authors:  Sunday Bisong; Richard Brown; Eme Osim
Journal:  N Am J Med Sci       Date:  2011-01

7.  Withanolide A prevents neurodegeneration by modulating hippocampal glutathione biosynthesis during hypoxia.

Authors:  Iswar Baitharu; Vishal Jain; Satya Narayan Deep; Sabita Shroff; Jayanta Kumar Sahu; Pradeep Kumar Naik; Govindasamy Ilavazhagan
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

Review 8.  Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective.

Authors:  Sumaira Saleem; Gulzar Muhammad; Muhammad Ajaz Hussain; Muhammad Altaf; Syed Nasir Abbas Bukhari
Journal:  Iran J Basic Med Sci       Date:  2020-12       Impact factor: 2.699

Review 9.  Plants and phytochemicals for Huntington's disease.

Authors:  Sunayna Choudhary; Puneet Kumar; Jai Malik
Journal:  Pharmacogn Rev       Date:  2013-07

Review 10.  Experimental treatment of antipsychotic-induced movement disorders.

Authors:  Erum Shireen
Journal:  J Exp Pharmacol       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.